BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borensztajn K, Peppelenbosch MP, Spek CA. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease? Trends in Pharmacological Sciences 2009;30:8-16. [DOI: 10.1016/j.tips.2008.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Seki K, Mizuno Y, Sakashita T, Nakano S, Tanno J, Okazaki Y, Muramatsu T, Nishimura S, Senbonmatsu T. Demeanor of rivaroxaban in activated/inactivated FXa. Journal of Pharmacological Sciences 2017;133:156-61. [DOI: 10.1016/j.jphs.2017.02.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Shawki MA, Elsayed NS, Mantawy EM, Said RS. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Immunopharmacol Immunotoxicol 2021;43:395-409. [PMID: 34057871 DOI: 10.1080/08923973.2021.1931302] [Reference Citation Analysis]
3 Torramade-Moix S, Palomo M, Vera M, Jerez D, Moreno-Castaño AB, Zafar MU, Rovira J, Diekmann F, Garcia-Pagan JC, Escolar G, Cases A, Diaz-Ricart M. Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia. Cardiovasc Drugs Ther 2021;35:521-32. [PMID: 32651897 DOI: 10.1007/s10557-020-07010-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Malz R, Weithauser A, Tschöpe C, Schultheiss HP, Rauch U. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis. Cardiovasc Ther 2014;32:113-9. [PMID: 24533719 DOI: 10.1111/1755-5922.12069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Merker M, Eichler S, Herrmann AM, Wiendl H, Kleinschnitz C, Göbel K, Meuth SG. Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis. J Neuroimmunol 2017;313:125-8. [PMID: 28992973 DOI: 10.1016/j.jneuroim.2017.08.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shi K, Queiroz KC, Roelofs JJ, van Noesel CJ, Richel DJ, Spek CA. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model: PAR-2 reduces metastasis in pancreatic cancer model. J Pathol 2014;234:398-409. [DOI: 10.1002/path.4411] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
7 Khandagale A, Kittner JM, Mann A, Ascher S, Kollar B, Reinhardt C. Coagulation factor 9-deficient mice are protected against dextran sulfate sodium-induced colitis. Biol Open 2018;7:bio034140. [PMID: 29945876 DOI: 10.1242/bio.034140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Queiroz KC, Van 't Veer C, Van Den Berg Y, Duitman J, Versteeg HH, Aberson HL, Groot AP, Verstege MI, Roelofs JJ, Te Velde AA, Spek CA. Tissue factor-dependent chemokine production aggravates experimental colitis. Mol Med 2011;17:1119-26. [PMID: 21717035 DOI: 10.2119/molmed.2011.00138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
9 Cugno M, Borghi A, Garcovich S, Marzano AV. Coagulation and Skin Autoimmunity. Front Immunol 2019;10:1407. [PMID: 31281319 DOI: 10.3389/fimmu.2019.01407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Scaldaferri F, Lancellotti S, Pizzoferrato M, Cristofaro RD. Haemostatic system in inflammatory bowel diseases: New players in gut inflammation. World J Gastroenterol 2011; 17(5): 594-608 [PMID: 21350708 DOI: 10.3748/wjg.v17.i5.594] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
11 Peppelenbosch MP. Kinome profiling. Scientifica (Cairo) 2012;2012:306798. [PMID: 24278683 DOI: 10.6064/2012/306798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
12 He Z, Si Y, Jiang T, Ma R, Zhang Y, Cao M, Li T, Yao Z, Zhao L, Fang S, Yu B, Dong Z, Thatte HS, Bi Y, Kou J, Yang S, Piao D, Hao L, Zhou J, Shi J. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thromb Haemost 2016;115:738-51. [PMID: 26660948 DOI: 10.1160/TH15-09-0710] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 5.9] [Reference Citation Analysis]
13 Abdel-Bakky MS, Helal GK, El-Sayed EM, Saad AS. Carbon tetrachloride-induced liver injury in mice is tissue factor dependent. Environ Toxicol Pharmacol. 2015;39:1199-1205. [PMID: 25982951 DOI: 10.1016/j.etap.2015.02.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Cugno M, Tedeschi A, Crosti C, Marzano AV. Activation of blood coagulation in autoimmune skin disorders. Expert Rev Clin Immunol 2009;5:605-13. [PMID: 20477646 DOI: 10.1586/eci.09.40] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
15 Cugno M, Tedeschi A, Asero R, Meroni PL, Marzano AV. Skin autoimmunity and blood coagulation. Autoimmunity 2010;43:189-94. [PMID: 19883336 DOI: 10.3109/08916930903293086] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
16 Borensztajn K, von der Thüsen JH, Peppelenbosch MP, Spek CA. The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm. J Cell Mol Med 2010;14:143-53. [PMID: 19968736 DOI: 10.1111/j.1582-4934.2009.00980.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]